CANF Operating Cash Flow Growth

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Operating Cash Flow Growth

CANF logo

CANF Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-13.86%
CANF TTM Cash from Operations YoY % (7.70% → -13.86%)
High-resolution chart · PNG

CANF operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-13.8633%
-15.4472%
-17.1796%
-48.2224%
-102.203%
-296.1845%
-2,319.2008%
-1,952.4655%
-867.3%
-100%
65.1852%
100%
100%
100%
100%
58.4444%
26.1596%
-5.7478%
-92.8173%
-47.3191%
-29.2729%
-18.2729%
19.3801%
7.6962%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.